Haemonetics Corporation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Haemonetics Corporation (HAE) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of 2.40% for the 12-month period ending 2025-03-29, per its 10-K filed 2026-05-20.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-05-20
- Haemonetics Corporation effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2025 was 2.40%, a 14.29% increase from fiscal 2024.
- Haemonetics Corporation effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was 2.10%, a 110.00% increase from fiscal 2023.
- Haemonetics Corporation effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was 1.00%, a 41.18% decline from fiscal 2022.
- Haemonetics Corporation effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was 1.70%, a 45.16% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed |
|---|---|---|
| 2025-03-29 | 2.40% 10-K · filed 2026-05-20 | |
| 2024-03-30 | 2.10% 10-K · filed 2026-05-20 | |
| 2023-04-01 | 1.00% 10-K · filed 2025-05-21 | |
| 2022-04-02 | 1.70% 10-K · filed 2024-05-20 | |
| 2021-04-03 | 3.10% 10-K · filed 2023-05-22 | |
| 2020-03-28 | 2.80% 10-K · filed 2022-05-25 | |
| 2019-03-30 | 2.20% 10-K · filed 2021-05-26 | |
| 2018-03-31 | 0.40% 10-K · filed 2020-05-20 | |
| 2017-04-01 | -0.10% 10-K · filed 2019-05-22 | -3.20% 10-K · filed 2017-05-24 |
| 2016-04-02 | -2.80% 10-K · filed 2018-05-23 | |
| 2015-03-28 | 4.00% 10-K · filed 2017-05-24 | |
| 2014-03-29 | 2.80% 10-K · filed 2016-06-01 | |
| 2013-03-30 | 2.40% 10-K · filed 2015-05-22 | |
| 2012-03-31 | 1.00% 10-K · filed 2014-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |